Asia-Pacific Acute Ischemic Stroke Treatment and Diagnosis Market is projected to reach $477.55 million by 2021

(EMAILWIRE.COM, December 18, 2017 ) Asia-Pacific Acute Ischemic Stroke Treatment and Diagnosis Market was worth $326.52 million in 2016 and estimated to be growing at a CAGR of 7.9%, to reach $477.55 million by 2021. Acute Ischemic stroke can be defined as loss of function in certain parts of brain due to lack of blood supply to the brain.







Asia Pacific is the most promising market for Acute Ischemic Stroke diagnosis and treatment owing to rising prevalence of acute ischemia stroke cases, technological advancements in surgical procedures along with rising aging population, increasing demand for minimally invasive procedures and growth in healthcare spending. High population base and growing incidence of cardiovascular are also major factors driving the market growth where as excessive usage of medication for the treatment of ischemic stroke and high cost of surgical procedures are some of the factors restraining the market growth.







Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market is analysed under two segments namely Diagnostic type and Surgery type. Diagnostic type is further sub-segmented into Computed Tomography, Ultrasound, Magnetic Resonance Imaging, Cerebral angiography and nuclear imaging. On the basis of Surgery Type the market is segmented into Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy. Carotid Endarterectomy is the largest surgery type segment accounting for a share of approximately XX% owing to high success rate, short treatment duration and easy availability.







View full report @ http://www.marketdataforecast.com/market-reports/asia-pacific-acute-ischemic-stroke-diagnosis-market-268/







On a geographical perspective Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market is analyzed under various regions namely China, India, Japan and Australia. Asia-Pacific is the most promising market for acute ischemic stroke diagnosis owing to increasing number of patients with cardiac related problems such as ischemic stroke. Manufacturers across various geographies are expanding their operations in Asia-Pacific region as these regions hold immense potential for the market growth.







Market Segmentation:



1 Diagnostic Type



1.1 Computed Tomography



1.2 Magnetic Resonance Imaging



1.3 Ultrasound



1.4 Cerebral angiography



1.5 Nuclear Imaging







2 Surgery Type



2.1 Carotid Endarterectomy



2.2 Angioplasty



2.3 Endovascular Mechanical Thrombectomy











Get free sample report @ http://www.marketdataforecast.com/market-reports/asia-pacific-acute-ischemic-stroke-diagnosis-market-268/request-sample







Some of the major companies covered in the report are Abbott Laboratories, Covidien plc, Philips Healthcare, Johnson & Johnson, Penumbra, Inc., GE Healthcare, Siemens Healthcare, Stryker Corporation (Concentric Medical, Inc.) and Hitachi, Ltd.





About Market Data Forecast

Market Data Forecast is a well versed market research firm catering solutions in the fields of market research, business intelligence and consulting. With a profound knowledge about the global market activities coupled with a customized approach. We render services in the most gripping markets like healthcare, agriculture and food & Beverages



More about Market Data Forecast



Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/

View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases



Market Data Forecast

Abhishek

+1-888- 702-9626

abhishek@marketdataforecast.com

Source: EmailWire.Com